Comment #4

jarasan — Tue, 07 Sep 2021 04:54:54 GMT

The key with this treatment is early detection, onset of symptoms. The powers that be know this and could stop this crap in its tracks using it as a prophylaxis. THE GD MONEY IS THE PROBLEM THE GREEDY BASTURDS ARE KILLING PEOPLE FOR FUQUING MONEY!!!!!!!!

Comment #3

sully16 — Mon, 06 Sep 2021 14:58:06 GMT

The same trolls who voted for a pedo and will defend him? why would anybody defend a pedo,...unless

Comment #2

jarasan — Mon, 06 Sep 2021 14:32:41 GMT

Oh yeah, it is real, just test the web page for search or any of the categories New, Videos, Clinical Trials.

Comment #1

jarasan — Mon, 06 Sep 2021 14:21:57 GMT

I also did this for the ignorant low IQ drone leftist trolls.

Original Blog Entry: NIH studies on Ivermectin, surprise, surprise golly gee.

jarasan — Mon, 06 Sep 2021 14:20:12 GMT

These papers are from some very deep internet research I did, you see I live near NIH and worked there.....well here are my results:

Sometimes the govt. gets it right.

Here are conclusions from just one study:

Conclusions:

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

Keywords: ivermectin, prophylaxis, treatment, COVID-19, SARS-CoV-2

https://search.nih.gov/search?utf8=%E2%9C%93 affiliate=nih query=ivermectin commit=Search

Here is a video of a nurse telling the truth of the epidemic of un-vaccinated:

https://www.redvoicemedia.com/2021/09/nurse-blows-the-lid-off-the-pandemic-of-the-unvaccinated-narrative/

U.S. Department of Health Human Services

A five-day course of ivermectin for the treatment of COVID ...

pubmed.ncbi.nlm.nih.gov/33278625/

Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 ...

Ivermectin for Prevention and Treatment of COVID-19 ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC8248252/

Ivermectin is not a new and experimental drug with an unknown safety profile. It is a WHO Essential Medicine already used in several different ...

Ivermectin | COVID-19 Treatment Guidelines

www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/

Ivermectin is a Food and Drug Administration (FDA)-approved antiparasitic drug that is used to treat several neglected tropical diseases, including ...

Ivermectin for Prevention and Treatment of COVID-19 ...

pubmed.ncbi.nlm.nih.gov/34469921/

Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical ...

Ivermectin for preventing and treating COVID-19

www.ncbi.nlm.nih.gov/pmc/articles/PMC8406455/

What is ivermectin? Ivermectin is a medicine used to treat parasites such as intestinal parasites in animals and scabies in humans. It is cheap and is ...

The mechanisms of action of Ivermectin against SARS-CoV-2 ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC8203399/

Ivermectin is enlisted in the World Health Organization s Model List of Essential Medicines . Drug repurposing, drug redirecting, or drug reprofiling ...

Ivermectin: a systematic review from antiviral effects to ...

pubmed.ncbi.nlm.nih.gov/32533071/

Ivermectin proposes many potentials effects to treat a range of diseases, with its antimicrobial, antiviral, and anti-cancer properties as a wonder ...

Use of ivermectin in the treatment of Covid-19: A pilot trial

pubmed.ncbi.nlm.nih.gov/33723507/

Ivermectin is safe in patients with SARS-CoV-2, reducing symptomatology and the SARS-CoV-2 viral load. This antiviral effect appears to depend on the ...

Ivermectin: a multifaceted drug of Nobel prize-honoured ...

pubmed.ncbi.nlm.nih.gov/34466270/

In 2015, the Nobel Committee for Physiology or Medicine, in its only award for treatments of infectious diseases since six decades prior, honoured the ...

Ivermectin for the treatment of COVID-19: A systematic ...

pubmed.ncbi.nlm.nih.gov/34181716/

Background: We systematically assessed benefits and harms of the use of ivermectin (IVM) in COVID-19 patients. Methods: Published and preprint ...

Serious adverse reactions associated with ivermectin: A ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC8087035/

Ivermectin is known to cause severe encephalopathies in subjects infected with loiasis, an endemic parasite in Sub-Saharan Africa (SSA). In addition ...

Review of the Emerging Evidence Demonstrating the Efficacy ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC8088823/

Ivermectin hastens recovery and prevents deterioration in patients with mild to moderate disease treated early after symptoms. 45,49 52,61,62. Ivermec ...

Ivermectin, Wonder drug from Japan: the human use ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740/

Ivermectin proved to be virtually purpose-built to combat Onchocerciasis, which has two main manifestations, dermal damage resulting from ...

Ivermectin for the Treatment of Coronavirus Disease 2019 ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC8394824/

Ivermectin (IVM) is a semisynthetic, anthelmintic agent for oral administration, and derived from the avermectins of Streptomyces avermitilis. IVM and ...

Effects of Ivermectin in Patients With COVID-19: A ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC8101859/

Ivermectin has been suggested as a potential COVID-19 treatment. 6 It is a US Food and Drug Administration (FDA)-approved broad-spectrum antiparasitic ...

Recent advances in management of COVID-19: A review

www.ncbi.nlm.nih.gov/pmc/articles/PMC8390390/

Ivermectin is approved by the FDA as an anti-parasite drug to treat onchocerciasis (river blindness), Malaria, head lice and scabies , . The class of ...

Ivermectin: a multifaceted drug of Nobel prize-honoured ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC8383101/

Introduction. The 2015 Nobel prize for the discovery of ivermectin (IVM) and an antimalarial treatment was the Nobel committee s first award for ...

Ivermectin | C48H74O14 - PubChem

pubchem.ncbi.nlm.nih.gov/compound/ivermectin

Ivermectin is an orally bioavailable macrocyclic lactone derived from Streptomyces avermitilis, with antiparasitic and potential anti-viral ...

Drug repurposing in COVID-19: A review with past, present ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC8387125/

Ivermectin, a broad-spectrum anti-parasitic agent has also been shown to be effective against some viral infections. Recently, this drug was studied ...

The FDA-approved drug ivermectin inhibits the replication ...

pubmed.ncbi.nlm.nih.gov/32251768/

We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor ...

... [ More ]